Compare BioNTech SE - ADR (BNTX) vs Workiva Inc (WK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Workiva Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Workiva Inc trades at $68 (market cap $3.76B). The key difference: BioNTech SE - ADR is far larger — about 6.2× Workiva Inc's market cap, and Workiva Inc is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | WK | |
|---|---|---|
Market Cap | $23.31B | $3.76B |
Sector | Health | Technology |
52-Week High | $119.34 | $93.31 |
52-Week Low | $83.89 | $44.31 |
Enterprise Value | $6.60B | $3.73B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Workiva Inc
Workiva is a leading provider of cloud-based platforms for complex reporting and compliance. It enables organizations to connect and manage data across financial reporting, ESG (Environmental, Social, and Governance), and GRC (Governance, Risk, and Compliance), serving as a single source of truth for auditable, transparent disclosures to regulators and stakeholders.
Read more on WK →
